Coherus Oncology, Inc. (CHRS)
1.63
-0.06
(-3.55%)
USD |
NASDAQ |
Mar 13, 16:00
1.635
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Total Assets (Quarterly) : 265.77M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 199.21B |
| Stereotaxis, Inc. | 52.25M |
| Allogene Therapeutics, Inc. | 415.90M |
| Inovio Pharmaceuticals, Inc. | 75.68M |
| Nektar Therapeutics | 280.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 204.76M |
| Shareholders Equity (Quarterly) | 61.01M |
| Debt to Equity Ratio | 0.891 |
| Current Ratio | 1.472 |
| Net Debt Paydown Yield | 28.50% |